CARRATU', Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 7.693
EU - Europa 1.556
AS - Asia 975
OC - Oceania 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 10.238
Nazione #
US - Stati Uniti d'America 7.682
CN - Cina 640
SE - Svezia 460
DE - Germania 284
SG - Singapore 256
UA - Ucraina 241
IT - Italia 196
FI - Finlandia 151
GB - Regno Unito 109
FR - Francia 33
VN - Vietnam 30
IN - India 29
IE - Irlanda 26
BE - Belgio 21
CZ - Repubblica Ceca 18
CA - Canada 11
NL - Olanda 7
IR - Iran 5
TR - Turchia 5
AU - Australia 4
TW - Taiwan 4
BR - Brasile 3
EU - Europa 3
ID - Indonesia 2
KR - Corea 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
EG - Egitto 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
VE - Venezuela 1
Totale 10.238
Città #
Fairfield 1.013
Woodbridge 861
Chandler 852
Jacksonville 570
Houston 546
Ashburn 512
Seattle 424
Nyköping 369
Ann Arbor 352
Cambridge 346
Wilmington 313
Singapore 192
Lawrence 176
Roxbury 175
Nanjing 171
Dearborn 142
Beijing 116
Des Moines 113
Boardman 88
New York 62
Bari 57
Princeton 46
San Diego 46
Hebei 44
Brooklyn 43
Shenyang 39
Inglewood 36
Jiaxing 34
Santa Clara 34
Dong Ket 28
Nanchang 28
Dublin 26
London 25
Hefei 24
Los Angeles 24
Changsha 22
Turi 22
Brussels 21
Helsinki 16
Kunming 16
Paris 16
Taranto 16
Tianjin 16
Munich 15
Olomouc 15
Pune 15
Redwood City 14
Jinan 13
Mottola 13
Guangzhou 11
Norwalk 10
Nürnberg 9
Auburn Hills 8
Hounslow 7
Toronto 7
Washington 7
Wuhan 7
Chengdu 6
Fuzhou 6
Prescot 6
Zhengzhou 6
Frankfurt am Main 5
Hyderabad 5
Leawood 5
Ardabil 4
Falls Church 4
Hangzhou 4
Huzhou 4
Shanghai 4
Taipei 4
Trani 4
Brno 3
Chiswick 3
Jinhua 3
New Bedfont 3
Ottawa 3
Putignano 3
Rome 3
Antalya 2
Augusta 2
Chicago 2
Chongqing 2
Easton 2
Formigine 2
Giugliano In Campania 2
Harbin 2
Jakarta 2
Kilburn 2
Marsala 2
Marseille 2
Milan 2
Montecorice 2
Nanning 2
New Delhi 2
Sanayi 2
Seelze 2
Spartanburg 2
Strasbourg 2
Sydney 2
São Paulo 2
Totale 8.355
Nome #
Voluntary lung function screening to reveal new COPD cases in southern Italy 190
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 131
An Electronic Nose Discriminates between the Exhaled Breath of Patients with Pleural Malignant Mesothelioma and Healthy Controls, 125
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 123
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 113
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 112
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 112
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 107
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 103
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 101
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 101
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 101
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 100
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 96
And the patient said: Let me be able to breathe and dream 96
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures 94
Lack of association between OSAS and Hypothyroidism 94
TITRATION EFFECTIVENESS OF TWO AUTOCPAP DEVICES DRIVEN BY DIFFERENT ALGORITHMS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA 93
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 93
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 93
Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. 92
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 91
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 91
Enviromental asbestos exposure as a risk factor for small airways obstruction 90
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 89
An electronic nose may sniff out amyotrophic lateral sclerosis 87
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 87
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 87
Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis 87
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 86
Electronic Nose Technology in Respiratory Diseases 85
In vitro identification of new transcriptomic and miRNomic profiles associated with pulmonary fibrosis induced by high doses everolimus: Looking for new pathogenetic markers and therapeutic targets 85
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 83
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 82
Smoking Habit in Severe Obese after bariatric procedures. 82
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 81
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 80
null 80
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 80
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 79
Home Unattended Portable Monitoring and AutoCPAP Titration In Patients With High Risk for Moderate to Severe OSA. 78
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? 78
Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease. 77
Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression 77
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 77
Excessive daytime sleepiness in women without OSA 76
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 76
Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. 75
Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management 75
Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives 74
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity 73
Hyperventilation In Patients With Pulmonary Arterial Hypertension Is Related To Increased Chemosensitivity 73
Predictive equations for CPAP titration in OSAS patients 73
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 71
null 71
Bilateral diaphragmatic paralysis after kidney surgery 70
ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. 70
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 70
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 69
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 68
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency 68
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 68
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 68
Alterazioni del metabolismo dell'endotelina-1 in pazienti con tromboembolia polmonare 67
A60 antigen, as a new tuberculin 66
Influence of obstructive sleep apnea on endothelial function in obese patients. 66
Abnormalities of Endothelin-1 metabolism in Pulmonary Embolism 66
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 66
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 66
Exhaled breath condensate as matrix for toluene detection: a preliminary study 62
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. 61
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 61
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 61
Aumento dell'escrezione urinaria di Endotelina-1 in pazienti affetti da BPCO 60
End points for pulmonary arterial hypertension: a way backward. 60
Endogenous Endothelin-1 production/excretion in patients with COPD 60
Lower SNIP value is correlated to the need of intubation in Amyotrophic Lateral Sclerosis 59
null 58
Zafirlukast single oral dose pre-treatment prevents FEV1 drop after bronchial challenge in mild asthma 58
24-hours Endothelin-1 urinary excretion in patients with Interstitial Lung Disease 57
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 56
Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP 56
null 56
Interleukin-8 and soluble intercellular adhesion molecule 1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment 55
Correlation between sniff nasal inspiratory pressure (snip) and amyotrophic lateral sclerosis functional rating scale (alsfrs) in als patients 55
An electronic nose in the diagnostic assessment of asthma in pediatric patients 55
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS. 55
Reversibility of the endothelial dysfunction after nasal CPAP therapy in OSAS patients 54
Cerebral heme-heme oxygenase-carbon monoxide-bilirubin system protects cerebral microvessels during seizures 54
Disfunzione endoteliale nella malattia vascolare polmonare ipossica 54
Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation 52
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 52
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 52
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 51
Effects of fixed compared to automatic CPAP on sleep in Obstructive Sleep Apnoea Syndrome. 51
Systemic and airways inflammation in healthy subjects of different ages 51
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 51
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 51
Epileptic seizures cause prolonged postictal cerebral vascular dysfunction that is ameliorated by HO-1 overexpression. 50
Studio SPET-TC cerebrale in pazienti affetti da BPCO 49
Totale 7.671
Categoria #
all - tutte 46.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.839 0 0 0 0 309 244 345 245 300 142 197 57
2020/20211.537 140 94 149 60 148 59 198 143 139 230 94 83
2021/20221.136 32 134 5 89 49 76 40 67 75 56 170 343
2022/20231.992 269 191 122 207 266 306 19 201 341 8 29 33
2023/2024621 52 127 38 43 67 136 39 34 4 20 4 57
2024/2025448 42 34 248 75 49 0 0 0 0 0 0 0
Totale 10.509